PROSTATE CANCER

Japan's Tokyo Komagome Hospital Dr. Okamoto and his colleagues selected 144 cases of pancreatic cancer patients, intraoperative radiotherapy and analysis of the efficacy of radiation therapy. Patients were divided into 2 groups: group 1 included 65 patients with unresectable tumors using shunt surgery; Group 2 included 68 cases of patients with tumor resection. In addition, the PWC study, 11 patients with radiation therapy from around the hemodynamic changes of pancreatic arterial infusion chemotherapy after them.

Treatment of prostate cancer patients with life expectancy and social relations, family and economic situation correspond to the current surgery and radiotherapy only hope to cure prostate cancer, but only a small number of patients suitable for both therapy. Many palliative therapy only, can ease symptoms, but the patient will not have an impact on survival. Therefore, treatment should be integrated in all aspects, the development of rational treatment programs. Current clinical treatment methods used as follows:

1. Endocrine therapy of prostate cancer with typical hormone-dependent, in clinical endocrine treatment of prostate lesions and can significantly ease symptoms, but with no obvious impact on survival.